{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:49:33Z","timestamp":1772012973913,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1"},{"start":{"date-parts":[[2016,5,6]],"date-time":"2016-05-06T00:00:00Z","timestamp":1462492800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","award":["RP-PG-0707-10\u2009149"],"award-info":[{"award-number":["RP-PG-0707-10\u2009149"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Addiction"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1111\/add.13385","type":"journal-article","created":{"date-parts":[[2016,3,19]],"date-time":"2016-03-19T07:24:42Z","timestamp":1458372282000},"page":"1616-1627","source":"Crossref","is-referenced-by-count":10,"title":["An economic evaluation of contingency management for completion of hepatitis B vaccination in those on treatment for opiate dependence"],"prefix":"10.1111","volume":"111","author":[{"given":"Rachid","family":"Rafia","sequence":"first","affiliation":[{"name":"Health Economics and Decision Science (HEDS), School of Health and Related Research, (ScHARR); University of Sheffield; Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J.","family":"Dodd","sequence":"additional","affiliation":[{"name":"Health Economics and Decision Science (HEDS), School of Health and Related Research, (ScHARR); University of Sheffield; Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"Brennan","sequence":"additional","affiliation":[{"name":"Health Economics and Decision Science (HEDS), School of Health and Related Research, (ScHARR); University of Sheffield; Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petra S.","family":"Meier","sequence":"additional","affiliation":[{"name":"Section of Public Health, School of Health and Related Research (ScHARR); University of Sheffield; Sheffield UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vivian D.","family":"Hope","sequence":"additional","affiliation":[{"name":"Injecting Drug Use Team, HIV and STI Department, Centre for Infectious Disease, Surveillance and Control; Public Health UK (PHE); London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortune","family":"Ncube","sequence":"additional","affiliation":[{"name":"Injecting Drug Use Team, HIV and STI Department, Centre for Infectious Disease, Surveillance and Control; Public Health UK (PHE); London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Byford","sequence":"additional","affiliation":[{"name":"Centre for the Economics of Mental and Physical Health; King's College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiong","family":"Tie","sequence":"additional","affiliation":[{"name":"Centre for the Economics of Mental and Physical Health; King's College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Metrebian","sequence":"additional","affiliation":[{"name":"National Addiction Centre, Addictions Department, Institute of Psychiatry, Psychology and Neuroscience; King's College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Hellier","sequence":"additional","affiliation":[{"name":"Department of Biostatistics; King's College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Weaver","sequence":"additional","affiliation":[{"name":"Department of Mental Health, Social Work and Integrative Medicine; Middlesex University; Hendon UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Strang","sequence":"additional","affiliation":[{"name":"National Addiction Centre, Addictions Department, Institute of Psychiatry, Psychology and Neuroscience; King's College London; London UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2016,5,6]]},"reference":[{"key":"10.1111\/add.13385-BIB0001|add13385-cit-0002","unstructured":"World Health Organization (WHO) Hepatitis B. Fact Sheet no. 204 2014"},{"key":"10.1111\/add.13385-BIB0002|add13385-cit-0003","unstructured":"Hepatitis B: The Green Book, chapter 18 2013"},{"key":"10.1111\/add.13385-BIB0003|add13385-cit-0004","volume-title":"The Global State of Harm Reduction 2010. Key Issues for Broadening the Response","author":"Walsh","year":"2010"},{"key":"10.1111\/add.13385-BIB0004|add13385-cit-0005","volume-title":"Health Protection Services and Microbiology Services Unlinked Anonymous Monitoring Survey of People Who Inject Drugs in Contact With Specialist Services: Data Tables, 2014","author":"Health Protection Agency","year":"2014"},{"key":"10.1111\/add.13385-BIB0005|add13385-cit-0006","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1365-2893.2007.00844.x","article-title":"Twenty years of selective hepatitis B vaccination: is hepatitis B declining among injecting drug users in England and Wales?","volume":"14","author":"Judd","year":"2007","journal-title":"J Viral Hepatol"},{"key":"10.1111\/add.13385-BIB0006|add13385-cit-0007","first-page":"71","article-title":"Failure to vaccinate current injecting drug users against hepatitis B in England and Wales","volume":"4","author":"Lamagni","year":"2001","journal-title":"Commun Dis Public Health"},{"key":"10.1111\/add.13385-BIB0007|add13385-cit-0008","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1017\/S0950268811000148","article-title":"Investigation of a large community-based outbreak of hepatitis B infection in the United Kingdom","volume":"140","author":"Andersson","year":"2012","journal-title":"Epidemiol Infect"},{"key":"10.1111\/add.13385-BIB0008|add13385-cit-0009","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0376-8716(00)00211-8","article-title":"Outcomes after methadone maintenance and methadone reduction treatments: two-year follow-up results from the National Treatment Outcome Research Study","volume":"62","author":"Gossop","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/add.13385-BIB0009|add13385-cit-0010","unstructured":"National Institute for Health and Care Excellence (NICE) Drug Misuse: Psychosocial Interventions (CG51) 2007"},{"key":"10.1111\/add.13385-BIB0010|add13385-cit-0011","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/bmj.39265.639641.AD","article-title":"Psychosocial interventions and opioid detoxification for drug misuse: summary of NICE guidance","volume":"335","author":"Pilling","year":"2007","journal-title":"BMJ"},{"key":"10.1111\/add.13385-BIB0011|add13385-cit-0012","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ypmed.2013.04.013","article-title":"A randomised controlled trial of financial incentives to increase hepatitis B vaccination completion among people who inject drugs in Australia","volume":"57","author":"Topp","year":"2013","journal-title":"Prev Med"},{"key":"10.1111\/add.13385-BIB0012|add13385-cit-0013","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0376-8716(03)00074-7","article-title":"A randomized controlled trial of monetary incentives vs. outreach to enhance adherence to the hepatitis B vaccine series among injection drug users","volume":"71","author":"Seal","year":"2003","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/add.13385-BIB0013|add13385-cit-0014","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.drugalcdep.2009.09.006","article-title":"Drug users' adherence to a 6-month vaccination protocol: effects of motivational incentives","volume":"107","author":"Stitzer","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1111\/add.13385-BIB0014|add13385-cit-0015","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0140-6736(14)60196-3","article-title":"Use of contingency management incentives to improve completion of hepatitis B vaccination in people undergoing treatment for heroin dependence: a cluster randomised trial","volume":"384","author":"Weaver","year":"2014","journal-title":"Lancet"},{"key":"10.1111\/add.13385-BIB0015|add13385-cit-0016","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1002\/hep.22898","article-title":"The natural history of chronic hepatitis B virus infection","volume":"49","author":"McMahon","year":"2009","journal-title":"Hepatology"},{"key":"10.1111\/add.13385-BIB0016|add13385-cit-0017","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1016\/S0168-8278(03)00139-9","article-title":"Natural history of hepatitis B","volume":"39","author":"Fattovich","year":"2003","journal-title":"J Hepatol"},{"key":"10.1111\/add.13385-BIB0017|add13385-cit-0018","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J Hepatol"},{"key":"10.1111\/add.13385-BIB0018|add13385-cit-0019","doi-asserted-by":"crossref","first-page":"S173","DOI":"10.1002\/hep.20956","article-title":"Natural history of chronic hepatitis B virus infection: what we knew in 1981 and what we know in 2005","volume":"43","author":"Yim","year":"2006","journal-title":"Hepatology"},{"key":"10.1111\/add.13385-BIB0019|add13385-cit-0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.amepre.2008.03.028","article-title":"Economic evaluation of delivering hepatitis B vaccine to injection drug users","volume":"35","author":"Hu","year":"2008","journal-title":"Am J Prev Med"},{"key":"10.1111\/add.13385-BIB0020|add13385-cit-0021","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.vaccine.2010.10.075","article-title":"Economic evaluation of infant and adolescent hepatitis B vaccination in the UK","volume":"29","author":"Siddiqui","year":"2011","journal-title":"Vaccine"},{"key":"10.1111\/add.13385-BIB0021|add13385-cit-0022","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1093\/eurpub\/ckm123","article-title":"Cost effectiveness of hepatitis B vaccination strategies in Ireland: an economic evaluation","volume":"18","author":"Tilson","year":"2008","journal-title":"Eur J Public Health"},{"key":"10.1111\/add.13385-BIB0022|add13385-cit-0023","unstructured":"National Institute for Health and Care Excellence (NICE). Hepatitis B (chronic) (CG165) 2013."},{"key":"10.1111\/add.13385-BIB0023|add13385-cit-0024","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1471-2334-6-93","article-title":"Modelling the force of infection for hepatitis B and hepatitis C in injecting drug users in England and Wales","volume":"6","author":"Sutton","year":"2006","journal-title":"BMC Infect Dis"},{"key":"10.1111\/add.13385-BIB0024|add13385-cit-0025","unstructured":"Health Protection Agency (HPA) Acute Hepatitis B (England): Annual Report for 2012 2014"},{"key":"10.1111\/add.13385-BIB0025|add13385-cit-0026","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/hep.26431","article-title":"Hepatitis C virus treatment for prevention among people who inject drugs: modeling treatment scale-up in the age of direct-acting antivirals","volume":"58","author":"Martin","year":"2013","journal-title":"Hepatology"},{"key":"10.1111\/add.13385-BIB0026|add13385-cit-0027","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.vaccine.2005.11.055","article-title":"Modelling the impact of prison vaccination on hepatitis B transmission within the injecting drug user population of England and Wales","volume":"24","author":"Sutton","year":"2006","journal-title":"Vaccine"},{"key":"10.1111\/add.13385-BIB0027|add13385-cit-0028","unstructured":"ENGERIX \u00ae -B Product Information 2014"},{"key":"10.1111\/add.13385-BIB0028|add13385-cit-0029","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/j.vaccine.2012.01.020","article-title":"Hepatitis B vaccination coverage and uptake in prisons across England and Wales 2003-2010: a retrospective ecological study","volume":"30","author":"Beck","year":"2012","journal-title":"Vaccine"},{"key":"10.1111\/add.13385-BIB0029|add13385-cit-0030","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1111\/j.1478-3231.2011.02682.x","article-title":"Management of severe acute to fulminant hepatitis B: to treat or not to treat or when to treat?","volume":"32","author":"Tillmann","year":"2012","journal-title":"Liver Int"},{"key":"10.1111\/add.13385-BIB0030|add13385-cit-0031","volume-title":"Guide to the Methods of Technology Appraisal","author":"National Institute for Health and Care Excellence (NICE)","year":"2013"},{"key":"10.1111\/add.13385-BIB0031|add13385-cit-0032","unstructured":"British National Formulary. BNF64 2014"},{"key":"10.1111\/add.13385-BIB0032|add13385-cit-0033","unstructured":"Curtis L. Unit Costs of Health and Social Care 2012"},{"key":"10.1111\/add.13385-BIB0033|add13385-cit-0034","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.1097\/00004836-200411003-00009","article-title":"Hepatitis B management costs in France, Italy, Spain, and the United Kingdom","volume":"38","author":"Brown","year":"2004","journal-title":"J Clin Gastroenterol"},{"key":"10.1111\/add.13385-BIB0034|add13385-cit-0035","unstructured":"National Health Service (NHS) NHS reference cost 2012-2013 2013"},{"key":"10.1111\/add.13385-BIB0035|add13385-cit-0036","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/hep.22138","article-title":"Health-related quality of life in chronic hepatitis B patients","volume":"47","author":"Ong","year":"2008","journal-title":"Hepatology"},{"key":"10.1111\/add.13385-BIB0036|add13385-cit-0037","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jval.2010.10.004","article-title":"Imputing QALYs from single time point health state descriptions on the EQ-5D and the SF-6D: a comparison of methods for hepatitis a patients","volume":"14","author":"Luyten","year":"2011","journal-title":"Value Health"},{"key":"10.1111\/add.13385-BIB0037|add13385-cit-0038","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jgh.12063","article-title":"Hepatitis B virus exposure and vaccination in a cohort of people who inject drugs: what has been the impact of targeted free vaccination?","volume":"28","author":"Winter","year":"2013","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1111\/add.13385-BIB0038|add13385-cit-0039","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0140-6736(15)60020-4","article-title":"Hepatitis B vaccination for people who inject drugs. Correspondence","volume":"385","author":"Hope","year":"2015","journal-title":"Lancet"}],"container-title":["Addiction"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.13385","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fadd.13385","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/add.13385\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T11:16:55Z","timestamp":1625311015000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/add.13385"}},"subtitle":["Contigency management in injecting drug users"],"short-title":[],"issued":{"date-parts":[[2016,5,6]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"URL":"https:\/\/doi.org\/10.1111\/add.13385","archive":["Portico"],"relation":{},"ISSN":["0965-2140"],"issn-type":[{"value":"0965-2140","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5,6]]}}}